empty
 
 
ro
Search
Support
Instant account opening
Trading Platform
Deposit/Withdraw
Search
Pentru Începători Pentru Traderi Pentru Parteneri Luați o pauză Despre InstaSpot
ro
Pentru Traderi
Grafice
#DVAX

#DVAX (Dynavax Technologies Corporation). Cursul de schimb și diagramele online.

#DHR Reveniți la lista instrumentelor #DXCM

Convertor valutar

Dynavax Technologies Corporation
10.89 USD
09 Dec 2025 22:59
Modificarea pretului (% chg)
$-0.02
(-0.18%)
Inchidere
Inchidere

Pretul de inchidere, ziua precedenta.
$10.96
Deschiderea
Deschiderea

Pretul de deschidere.
$10.93
Petul maxim
Petul maxim

Pretul maxim al ultimei zile de tranzactionare.
$11.12
Pretul minim
Pretul minim

Pretul minim al ultimei zile de tranzactionare.
$10.85
52-sapt. max.
52-sapt. max.

Pretul maxim din ultimele 52 spatamani.
$11.28
52-sapt. min.
52-sapt. min.

Pretul minim din ultimele 52 saptamani.
$10.62
Descărcați arhiva
Cumpărați
10.89
Vindeți
10.89
Deschideți graficul în ecran complet
Cumpărați
10.89
Vindeți
10.89
Descărcați arhiva
Deschideți graficul în ecran complet

Dynavax Technologies Corporation. About company

Dynavax Technologies Corporation is a biopharmaceutical company whose core business is the development and production of vaccines.

The company’s main product is a hepatitis B drug. The company also produces vaccines against coronavirus, influenza, plague, and other infectious diseases.

In addition, the company is mainly focused on the production of adjuvants. These substances help vaccines to be better absorbed by the body.

Currently, Dynavax has a market capitalization of $1.37 billion. Last year, the company posted revenues of $438.24 million and a net income of $76.71 million.

Dynavax Technologies Corporation’s shares and what affects their price

Dynavax shares have been trading on the NASDAQ exchange under the DVAX ticker since 2004. The initial price per share stood at $7.50.

Currently, the company’s shares are trading between $10 and $12. During the year, the share price was hovering between $7 and $22. At the same time, the company does not pay dividends to its shareholders.

What to pay attention to when trading the company’s shares:

  • Long-term growth prospects are driven by a large number of innovative developments;
  • The target price for the stock is several times higher than the current one, ranging between $45.5 and $48, according to forecasts;
  • Adjuvant technology is an advantage for the company since these additional substances significantly enhance the effect of the vaccines.

Nu puteti sa vorbiti acum?
Puneti intrebare in chat.